Comparative study of response to treatment and recurrence of brucellosis in the 4 and 6 week treatment groups with doxycycline, streptomycin and hydroxychloroquine.
Phase 3
- Conditions
- Brucellosis.Brucellosis
- Registration Number
- IRCT20160523028008N4
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 102
Inclusion Criteria
patients with sign and symptoms of brucellosis have Wright test of more than 1/160 and 2ME titer more than 1/80
Age of 18 years or older
Consent to participate in the study
Exclusion Criteria
being pregnant
Chronic Illnesses
Any serious complication of brucellosis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Response to treatment. Timepoint: at 1, 4, and 6 months after treatment. Method of measurement: through history taking and physical examination.;Recurrence. Timepoint: 4 and 6 months after treatmen. Method of measurement: Recurrence of the patient's clinical symptoms.
- Secondary Outcome Measures
Name Time Method Incidence of probable adverse effects such as hepatitis and visual impairment. Timepoint: at 1, 4, and 6 months after treatment. Method of measurement: through history taking and physical examination.